Reasoning
The VCEP permits PS2 for high-confidence somatic mutations when the specified tissue and parental-testing criteria are satisfied. The available literature contains somatic tumor observations of p.I1058F, including one report with wild-type matched normal tissue, but provides no affected brain-malformation proband, confirmed maternity and paternity, parental samples, or documentation that the variant was identified by a reporting CLIA laboratory. Therefore the available evidence cannot establish PS2_Strong or PS2_Moderate under the VCEP rule. The governing VCEP file was searched for c.3172A>T, p.Ile1058Phe, and p.I1058F, with no variant-specific pre-assigned PS2 entry found.
VCEP rule
Award the PS2_Strong point if Criteria 1 AND Criteria 2 are fulfilled. ... Criteria 1. The variant is present at a detectable allele fraction but is absent from parental samples with confirmed maternity and paternity. ... Criteria 2. The variant is present at a detectable allele fraction in an affected tissue sample but is absent from or detected at a lower allelic fraction in another tissue ... Award the PS2_Moderate point if Criteria 1 is fulfilled, OR if parents are not available but Criteria 2 is fulfilled. ... For the sake of implementation, these criteria are intended to apply to high-confidence somatic mutations identified by the reporting CLIA laboratory.
Evidence considered
- PMID:17062663 reports p.I1058F in one uterine endometrioid carcinoma and states that matched normal tissue was wild type, supporting a somatic tumor observation but not parental testing or a brain-malformation proband.
- PMID:33772212 reports p.I1058F in 2 of 8 cervical mesonephric carcinomas; no segregation, parental testing, or functional evidence is reported.
- PMID:31842489 lists c.3172A>T (p.Ile1058Phe) among somatic canine mammary-tumor mutations; no segregation or parental testing is reported.
- PMID:39369133 reports I1058F in a recurrent prostate-cancer tumor with a second PIK3CA mutation; no phase, germline testing, or parental testing is reported.
- The VCEP PS2 rule requires Criteria 1 and Criteria 2 for PS2_Strong; PS2_Moderate requires Criteria 1 or, when parents are unavailable, Criteria 2, and the implementation note limits these criteria to high-confidence somatic mutations identified by the reporting CLIA laboratory.
Still missing
- No confirmed maternity or paternity and no parental samples are available.
- No brain-malformation proband or affected brain tissue is documented.
- The literature reports do not establish identification by a reporting CLIA laboratory.
- No variant-specific entry for c.3172A>T, p.Ile1058Phe, or p.I1058F was found in clingen_brainmalform_acmg_specifications_v1_1.pdf.txt.
Sources